Danish pharma company on cusp of international success

Diabetes drug could be headed to the US

Danish pharmaceutical company Danske Zealand Pharma has taken a major step in capitalising on its diabetes product Lyxumia.

The Glostrup-based firm and its partner Sanofi has received approval for a US application for the composite product Lixilan.

Lixilan is a mixture of Danske Zealand Pharma’s Lyxumia and the world’s best-selling insulin, Lantus Sanofios.

Now that the application has been officially processed, the company will find out in August if its product has been approved.

“The US approval of the application is an important milestone in the regulatory process for this new type of diabetes drug,” said Danske Zealand Pharma head Britt Meelby Jensen.

Profitable combination
Lyxumia is a GLP-1 analog that acts by stimulating the pancreatic production of insulin. It is the same type of product as Novo Nordisk’s Victoza, which earned 18 billion kroner in 2015.

Lyxumia as a single agent earned Dansk Zealand Pharma 21 million kroner in royalties in the first nine months of 2015.

READ MORE: Danish diabetes treatment among the best in Europe

The combination product Lixilan could help to considerably increase sales of Lyxumia.

TOP STORIES

  • Danish Intelligence Service: Threat from Russia has intensified

    Danish Intelligence Service: Threat from Russia has intensified

    In the internal Danish waters, Russia will be able to attack underwater infrastructure from all types of vessels. The target could be cables with data, electricity and gas, assesses the Danish Defense Intelligence Service

  • Denmark to explore screening citizenship applicants for anti-democratic sentiments

    Denmark to explore screening citizenship applicants for anti-democratic sentiments

    A few weeks after Alex Vanopslagh’s comments about “right values,” the government announced that an expert committee would be established to examine the feasibility of screening citizenship applicants for anti-democratic attitudes.

  • The Future Copenhagen

    The Future Copenhagen

    The municipality plan encompasses building 40,000 houses by 2036 in order to help drive real estate prices down. But this is not the only huge project that will change the shape of the city: Lynetteholmen, M5 metro line, the Eastern Ring Road, and Jernbanebyen will transform Copenhagen into something different from what we know today

  • It’s not you: winter depression is affecting many people

    It’s not you: winter depression is affecting many people

    Many people in Denmark are facing hard times marked by sadness, anxiety, and apathy. It’s called winter depression, and it’s a widespread phenomenon during the cold months in Nordic countries.

  • Crime rates are rising, but people are safer

    Crime rates are rising, but people are safer

    Crime in Denmark is increasing for the second consecutive year, but it is more focused on property, while people appear to be safer than before. Over the past year, there were fewer incidents of violence

  • Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Despite Novo’s announcement that its growth abroad will be larger than in Denmark, the company announced this morning an 8.5 billion DKK investment for a new facility in Odense. This is the first time the company has established a new production site in Denmark this century.

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

Sign up here

Career

Want to advertise your job with CPH Post?

Contact us

Jobs